Investments and investor services
Top flight rises but Next disappoints
The FTSE 100 Index climbed 34 points to 6127 following yesterday's 150-point drop
Company
LON:OXB
Oxford BioMedica is a biopharmaceutical company specialising in the development and commercialisation of innovative gene-based medicines. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange. Oxford BioMedica's products use genes as the mediators of a therapeutic effect and/or immune response. The company has a platform of gene delivery technologies, which are predominately based on highly engineered viral systems. Oxford BioMedica has core expertise in gene delivery, as well as in-house clinical, regulatory and manufacturing know-how.
69 stories · page 4 of 4
Investments and investor services
The FTSE 100 Index climbed 34 points to 6127 following yesterday's 150-point drop
Investments and investor services
Below are the main news-driven share price movements at 4pm.
Investments and investor services
Stocks were on an upward trend, helped by a recovery by commodity plays
GlaxoSmithKline, BT and British American Tobacco led the way higher
Investments and investor services
Below are the main news-driven share price movements at 4pm.
Below are the main news-driven share price movements at 4pm.
Chinese markets rose "as state-directed investors bought shares"
Oil service providers Amec Foster Wheeler, Lamprell and Hunting, are scheduled to update the market on Thursday.
Trials have shown that immunotherapy may revolutionise cancer treatment